Breaking News

3P Bio, Zhittya Complete Process Transfer and GMP Supply for FGF-1 Candidate

3P completes transfer of the process for scaling up and performing cGMP manufacturing for clinical studies.

3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in process development and cGMP manufacturing of biologics, and Zhittya Genesis Medicine (Zhittya), a biotech company, have accomplished the process transfer and GMP supply of FGF-1 candidate.  3P and Zhittya began their relationship in 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achievi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters